US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1155-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1154-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1153-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1152-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1151-2023
Class II · Moderate risk Terminated

Sucralfate Oral Suspension 1g per 10mL

Reason Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

VistaPharm LLC NDC 66689-305-16 D-1149-2023
Class II · Moderate risk Terminated

Digoxin Tablets

Reason Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.

Marlex Pharmaceuticals, Inc. NDC 10135-0748-01 D-1170-2023
Class II · Moderate risk Completed

BD ChloraPrep Clear

Reason Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30¿C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides.

CareFusion 213, LLC NDC 54365-400-31 D-1168-2023
Class II · Moderate risk Terminated

Doxil

Reason CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.

Baxter Healthcare Corporation NDC 0338-0067-01 D-0048-2024
Class II · Moderate risk Terminated

Florbetaben F-18

Reason Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity Test (FIT).

Sofie Co dba Sofie NDC 54828-001-50 D-1177-2023
Class II · Moderate risk Ongoing

Humanrace Suncare

Reason Subpotent Drug: Product does not contain SPF that is declared on the label.

Humanrace D-1176-2023
Class II · Moderate risk Ongoing

Humanrace Suncare

Reason Subpotent Drug: Product does not contain SPF that is declared on the label.

Humanrace D-1175-2023
Class II · Moderate risk Terminated

dilTIAZem 125mg/125mL

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1138-2023
Class II · Moderate risk Terminated

dilTIAZem 125mg/125mL

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1137-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1136-2023
Class II · Moderate risk Terminated

heparin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1135-2023
Class II · Moderate risk Terminated

oxyTOCIN

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1134-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1131-2023
Class II · Moderate risk Terminated

EPINEPHrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services, Inc. D-1130-2023